Scholars Central

Research articlePublished 3 May 2019

Comparative study of efficacy of glimepiride and metformin versus glibenclamide and metformin for type 2 diabetic patients

Authors: Sivakumar R., Mohammed Rafy, Arya Mohan, Mohammed Shihab

Der Pharmacia Lettre

Volume 6 · Issue 1 · Pages 78–82

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Diabetes Mellitus is a syndrome with disordered metabolism and inappropriate hyperglycemia due to either a deficiency of insulin secretion or to a combination of insulin resistance and inadequate secretion to compensate. Type 2 diabetes is the most prevalent form and results from insulin resistance with a defect in compensatory insulin secretion. The study aims to compare the clinical efficacy of glimepiride plus metformin versus glibenclamide plus metformin in patients with type 2 diabetes mellitus and to assess the percentage reduction in fasting plasma glucose, post prandial glucose levels and HbA1C. A prospective observational study conducted for a period of 6 months. We included 96 type 2 diabetic patients in which 52 patients were taking glimepiride plus metformin (group A) and 44 patients were taking glibenclamide plus metformin (group B). A 'p' value of < 0.05 was considered to be statistically significant. The primary efficacy was measured by comparing HbA1C, FBS, PPBS and serum cholesterol level. After 6 months of treatment the HbA1C value decreased more significantly in group A (1.6%) than group B (1.29%), PPBS and cholesterol level also reduced more significantly in group A patients. But FBS value was more significantly reduced in group B patients. Glimepiride plus metformin combination therapy can be considered as the best combination in patients with increased glycaemic control as compared to glibenclamide plus metformin therapy.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Der Pharmacia Lettre.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalDer Pharmacia Lettre
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Sivakumar R.”
  • BylineArticles whose byline prints “Mohammed Rafy”
  • BylineArticles whose byline prints “Arya Mohan”
  • BylineArticles whose byline prints “Mohammed Shihab”